Utilizing our proprietary CytoTrapNanoTM technology, we isolate circulating tumor cells (CTC) from patient peripheral blood draw samples for biomarkers analysis.  Customized assays can be developed to accelerate our industry and academic collaborators’ drug and companion diagnostics development efforts.  For more information, please contact us at info@cytolumina.com